MX2024009755A - Metodos de purificacion de un producto. - Google Patents

Metodos de purificacion de un producto.

Info

Publication number
MX2024009755A
MX2024009755A MX2024009755A MX2024009755A MX2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A MX 2024009755 A MX2024009755 A MX 2024009755A
Authority
MX
Mexico
Prior art keywords
product
methods
purifying
affinity chromatography
purification
Prior art date
Application number
MX2024009755A
Other languages
English (en)
Spanish (es)
Inventor
Andreas Sebastian Zurbriggen
Carole In-Albon
Original Assignee
Kodiak Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kodiak Sciences Inc filed Critical Kodiak Sciences Inc
Publication of MX2024009755A publication Critical patent/MX2024009755A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244Interleukins [IL]
    • C07K16/248IL-6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2024009755A 2022-02-10 2023-02-09 Metodos de purificacion de un producto. MX2024009755A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263267810P 2022-02-10 2022-02-10
PCT/US2023/062322 WO2023154822A2 (en) 2022-02-10 2023-02-09 Methods of purifying a product

Publications (1)

Publication Number Publication Date
MX2024009755A true MX2024009755A (es) 2024-08-20

Family

ID=87521638

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024009755A MX2024009755A (es) 2022-02-10 2023-02-09 Metodos de purificacion de un producto.

Country Status (10)

Country Link
US (1) US20230250133A1 (https=)
EP (1) EP4476237A2 (https=)
JP (1) JP2025505696A (https=)
KR (1) KR20240142564A (https=)
CN (1) CN119032099A (https=)
AU (1) AU2023217074A1 (https=)
CA (1) CA3251000A1 (https=)
IL (1) IL314472A (https=)
MX (1) MX2024009755A (https=)
WO (1) WO2023154822A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015035342A2 (en) 2013-09-08 2015-03-12 Oligasis Llc Factor viii zwitterionic polymer conjugates
CA3059938A1 (en) 2017-04-14 2018-10-18 Kodiak Sciences Inc. Complement factor d antagonist antibodies and conjugates thereof
EP3758737A4 (en) 2018-03-02 2022-10-12 Kodiak Sciences Inc. IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
WO2025073922A1 (en) * 2023-10-04 2025-04-10 Sartorius Bia Separations D.O.O. Enhanced chromatographic separations of components in a mixture by employing chaotropic elution
WO2025184423A1 (en) * 2024-02-29 2025-09-04 Kodiak Sciences Inc. Cell-surface-targeting-domain-polymer-payload conjugate
WO2026055308A1 (en) * 2024-09-06 2026-03-12 Merck Sharp & Dohme Llc Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof
US20260092125A1 (en) * 2024-09-06 2026-04-02 Eyebiotech Limited Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof
WO2026075981A1 (en) * 2024-10-01 2026-04-09 Regeneron Pharmaceuticals, Inc. Methods of analyzing heterodimeric proteins
CN119454939A (zh) * 2024-11-28 2025-02-18 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液及其制备方法
CN119524125A (zh) * 2024-11-28 2025-02-28 北海康成(苏州)生物制药有限公司 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045314B2 (en) * 2000-04-04 2006-05-16 Baxter International Inc. Method for the production of bacterial toxins
WO2010147686A2 (en) * 2009-03-11 2010-12-23 Wyeth Llc Methods of purifying small modular immunopharmaceutical proteins
JP6162707B2 (ja) * 2011-10-24 2017-07-12 ハロザイム インコーポレイテッド 抗ヒアルロナン剤治療のためのコンパニオン診断およびその使用方法
CN105899540B (zh) * 2014-01-03 2020-02-07 豪夫迈·罗氏有限公司 双特异性抗-半抗原/抗-血脑屏障受体的抗体、其复合物及它们作为血脑屏障穿梭物的应用
MX380658B (es) * 2014-01-15 2025-03-11 Hoffmann La Roche Variantes de region fc con union mejorada de la proteina a.
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
PE20181363A1 (es) * 2015-09-23 2018-08-27 Genentech Inc Variantes optimizadas de anticuerpos anti-vegf
KR20250057128A (ko) * 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
EP3758737A4 (en) * 2018-03-02 2022-10-12 Kodiak Sciences Inc. IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF
US20210254073A1 (en) * 2020-02-04 2021-08-19 Cornell University Methods for capture and analysis of macromolecular complexes

Also Published As

Publication number Publication date
CA3251000A1 (en) 2023-08-17
KR20240142564A (ko) 2024-09-30
JP2025505696A (ja) 2025-02-28
IL314472A (en) 2024-09-01
WO2023154822A2 (en) 2023-08-17
AU2023217074A1 (en) 2024-08-15
CN119032099A (zh) 2024-11-26
WO2023154822A3 (en) 2023-09-21
EP4476237A2 (en) 2024-12-18
WO2023154822A8 (en) 2024-04-04
US20230250133A1 (en) 2023-08-10

Similar Documents

Publication Publication Date Title
MX2024009755A (es) Metodos de purificacion de un producto.
De Luca et al. Downstream processing of therapeutic peptides by means of preparative liquid chromatography
MX2015005178A (es) Purificacion de polipeptidos usando ultrafiltracion de flujo tangencial de etapa doble.
Roe Protein purification applications: a practical approach
PL374311A1 (en) Methods for purifying protein
WO2002083710A3 (en) Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
MX2013006611A (es) Tratamiento de formaciones iliticas al usar un agente quelante.
MX2012001263A (es) Metodo para purificar adamts13 recombinante y otras proteinas y sus composiciones.
RU2011137030A (ru) Способы очистки малых модулярных иммунофармацевтических белков
CN109096379B (zh) 一种枯草芽孢杆菌amep412蛋白的新功能及其抗菌肽的鉴定
US20250340589A1 (en) Purifying antibodies
Luong et al. A continuous affinity ultrafiltration process for trypsin purification
Dyr et al. Separation used for purification of recombinant proteins
SE8402861L (sv) Rening av biologiskt material
KR960701096A (ko) 그룹 B 스트렙토코커스의 많은 균주들에 대한 면역성을 제공하는 세포 표면 단백질인 Rib 단백질, 그 단백질의 정제방법, 시약키트 및 제약조성물(PROTEIN RIB. A CELL SURFACE PROTEIN THAT CONFERS IMMUNITY TO MANY STRAINS OF THE GROUP B STREPTOCOCCUS; PROCESS FOR PURIFICATION OF THE PROTEIN, PEAGENT KIT AND PHARMACEUTICAL COMPOSITION)
Gräslund et al. Integrated strategy for selective expanded bed ion-exchange adsorption and site-specific protein processing using gene fusion technology
Balekjian et al. Histones isolated from human parotid fluid
Mönster et al. One-step-purification of penicillin G amidase from cell lysate using ion-exchange membrane adsorbers
Garmidolova et al. Food-derived bioactive peptides-methods for purification and analysis
CN105112394A (zh) 一种能降解黄曲霉毒素b1的裂解酶的分离纯化方法
Recio et al. Method for the production of antibacterial peptides from biological fluids at an ionic membrane. Application to the isolation of nisin and caprine lactoferricin
Karabel’skii et al. Purification of the chimeric protein alburon16 from a culture medium of the yeast Pichia pastoris
CN116082471B (zh) 一种Cth TerA内含肽变体及其在生物法制备四肽-7中的应用
Miller et al. Biochemical characterization of the antimicrobial histone released by deoxyribonuclease and lactic acid
GEAP202516778A (en) Arginine wash in protein purification